BioMarin Pharmaceutical: Ian T. Clark Named As Chair

BioMarin Pharmaceutical announced that its Board of Directors has appointed Ian T. Clark as Chair of the Board, effective June 2, 2026, following his election at the company’s Annual Meeting of Stockholders. Clark will succeed Richard A. Meier, who is retiring after two decades of service. This transition marks a new phase for BioMarin as it continues to execute its long-term strategy and global expansion in rare disease treatments.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin